Abstract
Novel psychoactive drugs (NPDs) such as synthetic marijuana, bath salts, and salvia have increasingly entered into the American drug landscape. As law enforcement, researchers, and policy makers attempt to better understand, regulate, and detect these novel substances, other practitioners invested in drug abuse prevention and treatment may lack the knowledge to adequately handle patients and adolescents abusing NPDs. The current study employs interviews with 64 practitioners employed in positions that interact with potential recreational substance users in southeast Georgia in order to assess NPD knowledge, placing particular emphasis on those 22 respondents employed in public health, healthcare, or educational roles. Findings indicate that knowledge about NPDs among medical and educational practitioners is lacking, much of the information they ‘know’ is inaccurate, and that practitioners clearly recognize a need for NPD training. We discuss these findings relative to their broader impact on treatment and prevention programs.
Similar content being viewed by others
References
Agnich, L., Stogner, J., Miller, B., & Marcum, C. (2013). Purple drank prevalence and characteristics of misusers of codeine cough syrup mixtures. Addictive Behaviors, 38, 2445–2449.
American Association of Poison Control Centers. (2015a). Bath Salts Data. August 31, 2015. Retrieved from http://www.aapcc.org/
American Association of Poison Control Centers (2015b). Synthetic Cannabinoid Data. September 23, 2015. Retrieved from http://www.aapcc.org/
Centers for Disease Control and Prevention. (2013). Notes from the field: Acetyl fentanyl overdose fatalities. Morbidity and Mortality Weekly Report.
Clovis, J. B., Brillant, M. G. S., Matthews, D. C., Cobban, S. J., Romanow, P. R., Filiaggi, M. J., et al. (2012). Using interviews to construct and disseminate knowledge of oral health policy. International Journal of Dental Hygiene, 10(2), 91–97.
Corazza, I., Assi, S., Simonato, P., Corkery, J., Bersani, S., Demetrovics, Z., et al. (2013). Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: The outcomes of the rednet project. Human Psychopharmacology: Clinical and Experimental, 28, 317–323.
Drug Abuse Warning Network. (2013). 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency room visits. Substance Abuse and Mental Health Services Administration.
Drug Enforcement Administration. (2013). Kratom. Drug Enforcement Administration, Office of Diversion Control, Drug and Chemical Evaluation Section, January 2013.
EMCDDA. (2015). European Drug Report. Luxembourg: Publications Office of the European Union.
Food and Drug Safety and Innovation Act of 2012, S. 3187, 112th Congress (2012).
Griffin, O. H., Miller, B. L., & Khey, D. N. (2008). Legally high? legal considerations of salvia divinorum. Journal of Psychoactive Drugs, 40, 183–191.
Gunderson, E. W., Haughey, H. M., Ait-Daoud, N., Joshi, A. S., & Hart, C. L. (2012). “Spice” and “K2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. The American Journal on Addictions, 21(4), 320–326.
Hardey, M. (1999). Doctor in the house: The Internet as a source of lay health knowledge and the challenge to expertise. Sociology of Health & Illness, 21(6), 820–835.
Hart, M., Agnich, L. E., Stogner, J., & Miller, B. L. (2014). ‘Me and my drank:’Exploring the relationship between musical preferences and purple drank experimentation. American Journal of Criminal Justice, 39(1), 172–186.
Hassan, Z., Muzaimi, M., Navaratnam, V., Yusoff, N. H., Suhaimi, F. W., Vadivelu, R., et al. (2013). From kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neuroscience & Biobehavioral Reviews, 37(2), 138–151.
Johnston, L. D., O’Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Miech, R. A. (2014). Demographic subgroup trends among adolescents in the use of various licit and illicit drugs, 1975-2013.[Monitoring the Future Occasional Paper Series No. 81]. Ann Arbor, MI: The University of Michigan, Institute for Social Research.
Khey, D. N., Miller, B., & Griffin, O. (2008). Salvia divinorum use among a college student sample. Journal Of Drug Education, 38, 297–306.
Khey, D. N., Miller, B. L., & Stogner, J. (2014). Emerging trends in drug use and distribution. Switzerland: Springer.
Lank, P. M., Pines, E., & Mycyk, M. B. (2013). Emergency physicians’ knowledge of cannabinoid designer drugs. Western Journal of Emergency Medicine, 14(5), 467.
Linn, K. A., Long, M. T., & Pagel, P. S. (2014). “Robo-Tripping”: Dextromethorphan Abuse and its Anesthetic Implications. Anesthesiology and pain medicine, 4(5).
Los Angeles County Department of Public Health Substance Abuse Facts : “Bath Salts” (Synthetic Cathinones). Available at http://publichealth.lacounty.gov/sapc/FactSheet/BathSaltsFactSheet101512.pdf
Miller, B. L., Boman, J. H., & Stogner, J. (2013). Examining the measurement of novel drug perceptions: Salvia divinorum, gender, and peer substance use. Substance Use & Misuse, 48, 65–72.
Miller, B. L., Stogner, J. M., Agnich, L. E., Sanders, A., Bacot, J., & Felix, S. (2015). Marketing a panic: Media coverage of novel psychoactive drugs (NPDs) and its relationship with legal changes. American Journal of Criminal Justice, 40(3), 523–541.
Miller, B. L., Stogner, J. M., Khey, D. N., Akers, R. L., Boman, J., & Griffin, O. H. (2011). Magic mint, the internet, and peer associations: A test of social learning theory using patterns of salvia divinorum use. Journal of Drug Issues, 41, 305–326.
New York State Department of Public Health. Bath Salts and Synthetic Drugs. Available at https://www.health.ny.gov/professionals/narcotic/synthetic_drugs/
Peters, R. J., Kelder, S. H., Markham, C. M., Yacoubian, G. S., Peters, L. A., & Ellis, A. (2003). Beliefs and social norms about codeine and promethazine hydrochloride cough syrup (CPHCS) onset and perceived addiction among houstonian adolescents: An addiction trend in the city of lean. Journal of Drug Education, 33, 415–425.
Peters, R., Yacoubian, G. S., Rhodes, W., Forsythe, K. J., Bowers, K. S., Eulian, V. M., & Essien, E. J. (2007). Beliefs and social norms about codeine and promethazine hydrochloride cough syrup (CPHCS) use and addiction among multi-ethnic college students. Journal of Psychoactive Drugs, 39(3), 277–282.
Prisinzano, T. (2005). Psychopharmacology of the hallucinogenic sage Salvia divinorum. Life Sciences, 78, 527–53.
Roberts, J. R. (2013). In focus: Acetyl fentanyl: New drug of abuse more common than assumed. Emergency Medicine News, 35(12), 1–28.
ROCIC. (2015). Synthetic drugs: Synthetic cannabinoids, synthetic cathinones, dangerous to users, cops. Regional Organized Crime Information Center Special Research Report.
Shah, N. R. (2012). Dear Healthcare Provider Letter: Alert - Emerging Threat to Public Health Associated With the Use of Synthetic Cannabinoids
Spiller, H. A., Ryan, M. L., Weston, R. G., & Jansen, J. (2011). Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clinical Toxicology, 49, 499–505.
Stanciu, C. N., Penders, T. M., & Oxentine, H. N. (2015). Delusional infestation following misuse of prescription stimulants. Psychosomatics, 56(2), 210–212.
Stogner, J. M. (2014). The potential threat of acetyl fentanyl: Legal issues, contaminated heroin, and acetyl fentanyl “disguised” as other opioids. Annals of Emergency Medicine, 64(6), 637–9.
Stogner, J., Khey, D., Griffin, O., Miller, B., & Boman, J. (2012). Regulating a novel drug: An evaluation of changes in use of Salvia divinorum in the first year of Florida's ban. International Journal of Drug Policy, 23, 512–521.
Stogner, J. M., & Miller, B. L. (2014). A spicy kind of high: A profile of synthetic cannabinoid users. Journal of Substance Use, 19(1–2), 199–205. Suwanlert, 1975.
Suwanlert, S. (1975). A study of kratom eaters in Thailand. Bulletin on narcotics, 27(3), 21–27.
Topeff, J. M., Ellsworth, H., Willhite, L. A., Bangh, S. A., Edwards, E. M., & Cole, J. B. (2011). A case series of symptomatic patients, including one fatality, following 2C-E exposure. Clinical Toxicology, 49(6), 526–526.
Winder, G. S., Stern, N., & Hosanagar, A. (2013). Are “Bath Salts” the next generation of stimulant abuse? Journal of Substance Abuse Treatment, 44(1), 42–45.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stogner, J.M., Khey, D.N., Agnich, L.E. et al. They Were Getting High on What? Evaluating Novel Psychoactive Drug Knowledge Among Practitioners. Am J Crim Just 41, 97–111 (2016). https://doi.org/10.1007/s12103-015-9327-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12103-015-9327-1